Riesman's sign

From WikiMD's WELLNESSPEDIA


Riesman's sign
Synonyms
Pronounce N/A
Specialty Cardiology
Symptoms Bruit over the sternum
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes Aortic regurgitation
Risks N/A
Diagnosis Physical examination
Differential diagnosis
Prevention N/A
Treatment
Medication N/A
Prognosis N/A
Frequency
Deaths N/A


Riesman's sign is a clinical sign in which there is a change in the rhythm of the pulse in cases of aortic insufficiency. It is named after the German physician David Riesman (1867–1940).

Definition[edit]

Riesman's sign is defined as a change in the rhythm of the pulse in cases of aortic insufficiency. This sign is named after the German physician David Riesman, who first described it in the late 19th century. Aortic insufficiency, also known as aortic regurgitation, is a condition where the aortic valve in the heart does not close tightly, allowing blood to flow back into the left ventricle.

Clinical Significance[edit]

Riesman's sign is used as a diagnostic tool in the detection of aortic insufficiency. It is not a definitive diagnostic tool, but it can provide valuable information in the clinical assessment of a patient with suspected aortic insufficiency. The presence of Riesman's sign, along with other clinical signs and symptoms, can suggest the need for further diagnostic testing, such as echocardiography.

See Also[edit]

References[edit]

  • Riesman D. The pulse in aortic insufficiency. JAMA. 1897;29:495‚Äì497.
  • Riesman D. The clinical significance of the pulse in aortic insufficiency. JAMA. 1900;35:139‚Äì142.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.